Axcella Health (NASDAQ:AXLA) posted its earnings results on Monday. The company reported ($0.68) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.64) by ($0.04), MarketWatch Earnings reports.
Shares of NASDAQ AXLA opened at $2.95 on Wednesday. The stock’s 50-day moving average is $3.93 and its two-hundred day moving average is $4.60. The company has a debt-to-equity ratio of 0.33, a current ratio of 11.75 and a quick ratio of 11.75. Axcella Health has a 1-year low of $2.25 and a 1-year high of $15.99. The company has a market cap of $62.41 million and a price-to-earnings ratio of -0.61.
In related news, Director David R. Epstein purchased 12,800 shares of the business’s stock in a transaction on Thursday, February 27th. The shares were bought at an average price of $3.65 per share, for a total transaction of $46,720.00. Following the acquisition, the director now directly owns 66,098 shares in the company, valued at $241,257.70. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last 90 days, insiders have acquired 17,465 shares of company stock worth $69,689.
About Axcella Health
There is no company description available for Axcella Health Inc
Recommended Story: What is a growth and income fund?
Receive News & Ratings for Axcella Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcella Health and related companies with MarketBeat.com's FREE daily email newsletter.